Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligand

Bioconjugate Chemistry

Volumn 23, Issue 12, 2012, Pages 2451-2459

  Tafreshi, Narges K ^a   Huang, Xuan ^a   Moberg, Valerie E ^a   Barkey, Natalie M ^a   Sondak, Vernon K ^a   Tian, Haibin ^a   Morse, David L ^a   Vagner, Josef ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CHELATION; DERMATOLOGY; DIAGNOSIS; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; INFRARED DEVICES; LIGANDS; ONCOLOGY; PATHOLOGY; PROBES;

FLUORESCENCE IMAGING; HIGH AFFINITY; HIGH SPECIFICITY; IMAGING PROBE; MALIGNANT MELANOMA; MELANOCORTINS; MELANOMA METASTASIS; PEPTIDOMIMETICS; RECEPTOR EXPRESSION; SYNTHESIS AND CHARACTERIZATIONS;

TUMORS;

MELANOCORTIN 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONJUGATION; CONTROLLED STUDY; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MOLECULAR PROBE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

EID: 84871313160     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300549s     Document Type: Article

References (46)

1. Siegel, R., Naishadham, D., and Jemal, A. (2012) Cancer statistics, 2012 CA Cancer J. Clin. 62, 10-29
2. Thompson, J. F. and Uren, R. F. (2005) Lymphatic mapping in management of patients with primary cutaneous melanoma Lancet Oncol. 6, 877-85
3. Balch, C. M., Soong, S. J., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., Atkins, M. B., Thompson, J. A., Coit, D. G., Byrd, D., Desmond, R., Zhang, Y., Liu, P. Y., Lyman, G. H., and Morabito, A. (2001) Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J. Clin. Oncol. 19, 3622-34
4. Kalady, M. F., White, R. R., Johnson, J. L., Tyler, D. S., and Seigler, H. F. (2003) Thin melanomas: predictive lethal characteristics from a 30-year clinical experience Ann. Surg. 238, 528-35 discussion 535-7.
5. Caudle, A. S. and Ross, M. I. (2011) Metastasectomy for stage IV melanoma: for whom and how much? Surg. Oncol. Clin. N. Am. 20, 133-44
6. Ott, P. A. and Berman, R. S. (2011) Surgical approach to primary cutaneous melanoma Surg. Oncol. Clin. N. Am. 20, 39-56
7. Nguyen, Q. T., Olson, E. S., Aguilera, T. A., Jiang, T., Scadeng, M., Ellies, L. G., and Tsien, R. Y. (2010) Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival Proc. Natl. Acad. Sci. U. S. A. 107, 4317-22
8. van Dam, G. M., Themelis, G., Crane, L. M., Harlaar, N. J., Pleijhuis, R. G., Kelder, W., Sarantopoulos, A., de Jong, J. S., Arts, H. J., van der Zee, A. G., Bart, J., Low, P. S., and Ntziachristos, V. (2011) Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results Nat. Med. 17, 1315-9
9. Frangioni, J. V. (2008) New technologies for human cancer imaging J. Clin. Oncol. 26, 4012-21
10. Keereweer, S., Kerrebijn, J. D., van Driel, P. B., Xie, B., Kaijzel, E. L., Snoeks, T. J., Que, I., Hutteman, M., van der Vorst, J. R., Mieog, J. S., Vahrmeijer, A. L., van de Velde, C. J., Baatenburg de Jong, R. J., and Lowik, C. W. (2011) Optical image-guided surgery - where do we stand? Mol. Imaging Biol. 13, 199-207
11. Balch, C. M. (1985) [Diagnosis and prognosis of malignant melanoma] Dtsch. Med. Wochenschr. 110, 1783-6
12. Hinz, T., Ahmadzadehfar, H., Wierzbicki, A., Hoeller, T., Wenzel, J., Biersack, H. J., Bieber, T., and Schmid-Wendtner, M. H. (2012) Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institution Eur. J. Nucl. Med. Mol. Imaging 39, 1316-25
13. Hettiaratchy, S. P., Kang, N., O'Toole, G., Allan, R., Cook, M. G., and Powell, B. W. (2000) Sentinel lymph node biopsy in malignant melanoma: a series of 100 consecutive patients Br. J. Plast. Surg. 53, 559-62
14. Cigna, E., Gradilone, A., Ribuffo, D., Gazzaniga, P., Fino, P., Sorvillo, V., and Scuderi, N. (2012) Morbidity of selective lymph node biopsy for melanoma: meta-analysis of complications Tumori 98, 94-8
15. Crane, L. M., Themelis, G., Buddingh, K., Harlaar, N. J., Pleijhuis, R. G., Sarantopoulos, A., van der Zee, A. G., Ntziachristos, V., and van Dam, G. M. (2010) Multispectral real-time fluorescence imaging for intraoperative detection of the sentinel lymph node in gynecologic oncology J. Vis. Exp. 44, 2225
16. Wagner, J. D. (2004) A role for FDG-PET in the surgical management of stage IV melanoma Ann. Surg. Oncol. 11, 721-2
17. Hsu, M., Andl, T., Li, G., Meinkoth, J. L., and Herlyn, M. (2000) Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression J. Cell Sci. 113 (Pt 9) 1535-42
18. Wang, R., Kobayashi, R., and Bishop, J. M. (1996) Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor Proc. Natl. Acad. Sci. U. S. A. 93, 8425-30
19. Yang, P., Farkas, D. L., Kirkwood, J. M., Abernethy, J. L., Edington, H. D., and Becker, D. (1999) Macroscopic spectral imaging and gene expression analysis of the early stages of melanoma Mol. Med. 5, 785-94
20. Siegrist, W., Solca, F., Stutz, S., Giuffre, L., Carrel, S., Girard, J., and Eberle, A. N. (1989) Characterization of receptors for alpha-melanocyte- stimulating hormone on human melanoma cells Cancer Res. 49, 6352-8
21. Cai, M., Varga, E. V., Stankova, M., Mayorov, A., Perry, J. W., Yamamura, H. I., Trivedi, D., and Hruby, V. J. (2006) Cell signaling and trafficking of human melanocortin receptors in real time using two-photon fluorescence and confocal laser microscopy: differentiation of agonists and antagonists Chem. Biol. Drug Des. 68, 183-93
22. Koikov, L. N., Ebetino, F. H., Solinsky, M. G., Cross-Doersen, D., and Knittel, J. J. (2003) Sub-nanomolar hMC1R agonists by end-capping of the melanocortin tetrapeptide His-D-Phe-Arg-Trp-NH(2) Bioorg. Med. Chem. Lett. 13, 2647-50
23. Mayorov, A. V., Han, S. Y., Cai, M., Hammer, M. R., Trivedi, D., and Hruby, V. J. (2006) Effects of macrocycle size and rigidity on melanocortin receptor-1 and -5 selectivity in cyclic lactam alpha-melanocyte-stimulating hormone analogs Chem. Biol. Drug Des. 67, 329-35
24. Geschwind, I. I., Huseby, R. A., and Nishioka, R. (1972) The effect of melanocyte-stimulating hormone on coat color in the mouse Recent Prog. Horm. Res. 28, 91-130
25. Hunt, G., Kyne, S., Wakamatsu, K., Ito, S., and Thody, A. J. (1995) Nle4DPhe7 alpha-melanocyte-stimulating hormone increases the eumelanin:phaeomelanin ratio in cultured human melanocytes J. Invest. Dermatol. 104, 83-5
26. Tamate, H. B. and Takeuchi, T. (1984) Action of the e locus of mice in the response of phaeomelanic hair follicles to alpha-melanocyte-stimulating hormone in vitro Science 224, 1241-2
27. Gong, R. (2012) The renaissance of corticotropin therapy in proteinuric nephropathies Nat. Rev. Nephrol. 8, 122-8
28. Chen, J., Giblin, M. F., Wang, N., Jurisson, S. S., and Quinn, T. P. (1999) In vivo evaluation of 99mTc/188Re-labeled linear alpha-melanocyte stimulating hormone analogs for specific melanoma targeting Nucl. Med. Biol. 26, 687-93
29. Cai, M., Mayorov, A. V., Cabello, C., Stankova, M., Trivedi, D., and Hruby, V. J. (2005) Novel 3D pharmacophore of alpha-MSH/gamma-MSH hybrids leads to selective human MC1R and MC3R analogues J. Med. Chem. 48, 1839-48
30. Handl, H. L., Vagner, J., Yamamura, H. I., Hruby, V. J., and Gillies, R. J. (2004) Lanthanide-based time-resolved fluorescence of in cyto ligand-receptor interactions Anal. Biochem. 330, 242-50
31. Yang, Y., Hruby, V. J., Chen, M., Crasto, C., Cai, M., and Harmon, C. M. (2009) Novel binding motif of ACTH analogues at the melanocortin receptors Biochemistry 48, 9775-84
32. Barkey, N. M., Tafreshi, N. K., Josan, J. S., De Silva, C. R., Sill, K. N., Hruby, V. J., Gillies, R. J., Morse, D. L., and Vagner, J. (2011) Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand J. Med. Chem. 54, 8078-84
33. Morse, D. L., Carroll, D., Weberg, L., Borgstrom, M. C., Ranger-Moore, J., and Gillies, R. J. (2005) Determining suitable internal standards for mRNA quantification of increasing cancer progression in human breast cells by real-time reverse transcriptase polymerase chain reaction Anal. Biochem. 342, 69-77
34. Xu, L., Vagner, J., Alleti, R., Rao, V., Jagadish, B., Morse, D. L., Hruby, V. J., Gillies, R. J., and Mash, E. A. (2010) Synthesis and characterization of a Eu-DTPA-PEGO-MSH(4) derivative for evaluation of binding of multivalent molecules to melanocortin receptors Bioorg. Med. Chem. Lett. 20, 2489-92
35. Cheng, Z., Xiong, Z., Subbarayan, M., Chen, X., and Gambhir, S. S. (2007) 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression Bioconjugate Chem. 18, 765-72
36. Baumann, J. B., Bagutti, C., Siegrist, W., Christen, E., Zumsteg, U., and Eberle, A. N. (1997) MSH receptors and the response of human A375 melanoma cells to interleukin-1 beta J. Recept. Signal Transduct. Res. 17, 199-210
37. Abell, A. (1997) Advances in Amino Acid Mimetics and Peptidomimetics, 1st ed.; Vol. 1, JAI Press, Greenwich, CT.
38. Bullok, K. E., Gammon, S. T., Violini, S., Prantner, A. M., Villalobos, V. M., Sharma, V., and Piwnica-Worms, D. (2006) Permeation peptide conjugates for in vivo molecular imaging applications Mol. Imaging 5, 1-15
39. Knight, L. C. (2003) Non-oncologic applications of radiolabeled peptides in nuclear medicine Q. J. Nucl. Med. 47, 279-91
40. Okarvi, S. M. (2001) Recent progress in fluorine-18 labelled peptide radiopharmaceuticals Eur. J. Nucl. Med. 28, 929-38
41. Okarvi, S. M. (2004) Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases Med. Res. Rev. 24, 357-97
42. Koikov, L. N., Ebetino, F. H., Solinsky, M. G., Cross-Doersen, D., and Knittel, J. J. (2004) Analogs of sub-nanomolar hMC1R agonist LK-184 [Ph(CH2)3CO-His-D-Phe-Arg-Trp-NH2]. An additional binding site within the human melanocortin receptor 1? Bioorg. Med. Chem. Lett. 14, 3997-4000
43. Di, L. and Kerns, E. H. (2003) Profiling drug-like properties in discovery research Curr. Opin. Chem. Biol. 7, 402-8
44. Cheng, Z., Zhang, L., Graves, E., Xiong, Z., Dandekar, M., Chen, X., and Gambhir, S. S. (2007) Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog J. Nucl. Med. 48, 987-94
45. Stein, W. D., Litman, T., Fojo, T., and Bates, S. E. (2004) A Serial Analysis of Gene Expression (SAGE) database analysis of chemosensitivity: comparing solid tumors with cell lines and comparing solid tumors from different tissue origins Cancer Res. 64, 2805-16
46. Razansky, D., Deliolanis, N. C., Vinegoni, C., and Ntziachristos, V. (2012) Deep tissue optical and optoacoustic molecular imaging technologies for pre-clinical research and drug discovery Curr. Pharm. Biotechnol. 13, 504-22